ArticleBMC musculoskeletal disorders2025
Comparison of the clinical outcomes and radiological parameters between the greater tuberosity strengthened proximal humeral plate and the proximal humeral internal locking system plate in the minimally invasive plate osteosynthesis treatment of proximal humeral fractures involving the greater tuberosity: a retrospective cohort study.
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Current Evidence and Surgical Strategies in the Management of Greater Tuberosity Fracture-Dislocations: A Narrative Review.Journal of clinical medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWith the gradual promotion of minimally invasive plate osteosynthesis (MIPO) in the treatment of proximal humeral fractures, some patients using the proximal humeral internal locking system (PHILOS) plate experience significant displacement of the fixed greater tuberosity. However, this is rarely seen in patients using a new plate named the greater tuberosity strengthened proximal humeral plate (GTSPHP). Notably, a comparison of these two plates is lacking. Therefore, we aimed to retrospectively compare the clinical outcomes and radiological parameters of MIPO using the GTSPHP and PHILOS plates.
methodsThe data of 40 patients with proximal humeral fractures involving the greater tuberosity who underwent MIPO performed by the same physician between 1 April 2019 and 31 December 2022 were retrospectively analysed. Sixteen and 24 patients were included in the GTSPHP and PHILOS plate groups, respectively and followed up for at least 1 year postoperatively. General clinical characteristics, perioperative data, postoperative follow-up clinical outcomes, complications, and reduction loss of the greater tuberosity were compared between the two groups.
resultsNo significant differences were found in age, sex, affected side, injury mechanism, fracture type, injury to surgery time, operative time, postoperative hospital stay, the shortened version of the Disabilities of the Arm, Shoulder, and Hand questionnaire (QuickDASH) score, and Constant score between the two groups. However, the GTSPHP group was superior to the PHILOS plate group regarding surgical incision length, intraoperative blood loss, and the 11-point numerical rating scale score on the first, second and third postoperative days. In the PHILOS plate group, three patients had fracture malunion; both groups showed no signs of incision infection, fracture non-union, screw cut-out, or subacromial impingement syndrome. Both groups showed no significant differences in complication rates. The risk of reduction loss of greater tuberosity was lower in the GTSPHP group than in the PHILOS plate group.
conclusionsOur study showed that in MIPO treatment of proximal humeral fractures involving the greater tuberosity, the GTSPHP outperformed the PHILOS plate in terms of intraoperative blood loss, surgical incision length, short-term postoperative pain, and fixation capability of the greater tuberosity. However, further research is needed to confirm these findings. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.